Amitha Shetty
Amitha Shetty has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Akhilesh Dubey
Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Mangalore, India
5 shared publications Akhilesh Dubey
Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics , Mangaluru, Karnataka 575018
3 shared publications- Manohar Mahadev
Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics, Mangalore, India
3 shared publications Manohar Mahadev
Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences (NGSMIPS), Department of Pharmaceutics , Mangaluru, Karnataka 575018
2 shared publicationsSrinivas Hebbar
Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education , Manipal, Karnataka 576104
2 shared publicationsAlafiya Matcheswala
Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (10) , 1232
Phytosomal Delivery of Natural Bioactives: Advancing Bioavailability, Targeted Drug Delivery, and Clinical Translation
Natural bioactive compounds, especially plant-derived phytoconstituents, have gained significant interest due to their structural diversity, multitarget pharmacological activities, and favourable safety profiles. Their pharmaceutical translation is often hindered by poor aqueous solubility, limited membrane permeability, chemical instability, extensive first-pass metabolism, and, therefore, low oral bioavailability. Phytosomes, which are molecular complexes of bioactive compounds with phospholipids, have emerged as a new, effective, lipid-based delivery platform that can overcome these biopharmaceutical limitations and improve solubility, membrane interactions, systemic exposure, and therapeutic efficacy. The present review critically analyses recent advancements in phytosomal drug delivery, from formulation development to clinical translation, focusing on molecular complexation mechanisms, formulation strategies, physicochemical characterisation, pharmacokinetic enhancement, therapeutic applications, and challenges in clinical translation. The current review combines pharmaceutical design principles with recent advances in quality-by-design (QbD), computational formulation optimisation, hybrid phytosomal systems, scalable manufacturing approaches, and targeted delivery strategies. In addition, prospects for the future extension of phospholipid complexation to bioactive compounds from marine organisms, fungi, microorganisms, and algae are discussed in relevance to the next-generation natural product therapeutics. The present review serves as an emerging link between the discovery of natural bioactive compounds and the development of clinically translatable phytosomal systems from a pharmaceutical perspective.
- 29 September 2026
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (10) , 1232
Open AccessPhytosomal Delivery of Natural Bioactives: Advancing Bioavailability, Targeted Drug Delivery, and Clinical Translation
Natural bioactive compounds, especially plant-derived phytoconstituents, have gained significant interest due to their structural diversity, multitarget pharmacological activities, and favourable safety profiles. Their pharmaceutical translation is often hindered by poor aqueous solubility, limited membrane permeability, chemical instability, extensive first-pass metabolism, and, therefore, low oral bioavailability. Phytosomes, which are molecular complexes of bioactive compounds with phospholipids, have emerged as a new, effective, lipid-based delivery platform that can overcome these biopharmaceutical limitations and improve solubility, membrane interactions, systemic exposure, and therapeutic efficacy. The present review critically analyses recent advancements in phytosomal drug delivery, from formulation development to clinical translation, focusing on molecular complexation mechanisms, formulation strategies, physicochemical characterisation, pharmacokinetic enhancement, therapeutic applications, and challenges in clinical translation. The current review combines pharmaceutical design principles with recent advances in quality-by-design (QbD), computational formulation optimisation, hybrid phytosomal systems, scalable manufacturing approaches, and targeted delivery strategies. In addition, prospects for the future extension of phospholipid complexation to bioactive compounds from marine organisms, fungi, microorganisms, and algae are discussed in relevance to the next-generation natural product therapeutics. The present review serves as an emerging link between the discovery of natural bioactive compounds and the development of clinically translatable phytosomal systems from a pharmaceutical perspective.
- Open Access
- 7 September 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 98-107
Integrating Quality by Design and Design of Experiments for Scalable Nanoparticle Therapeutics: A Comprehensive Review
Nanoparticle-based drug delivery systems have tremendous advantages over the conventional dosage forms in terms of enhancing bioavailability, controlled release and tissue-specific targeting. However, despite great success at laboratory scale, the translation and commercialization of nanomedicines is still limited, mainly due to the inherent complexity of nanosystems, variability of the manufacturing processes and lack of globally unified regulatory frameworks. Integrating quality by design (QbD) with design of experiments (DoE) offers a scientific process for filling these gaps with more comprehensive formulation and understanding of processes. This review outlines QbD driven methodologies employed in the development of nanoparticles with a focus on the systematic determination of the quality target product profile (QTPP), critical quality attributes (CQAs), critical material attributes (CMAs), and critical process parameters (CPPs). The usefulness of DoEin screening and optimization methodology and multifactorial variables of formulation types is reviewed as a tool to derive robust design spaces and promote and provide predictive activity of nanoparticles such as particle size, polydispersity, drug loading, release kinetics, stability, etc. Updated knowledge about globally approved nanotechnology-based products is in the light of the rising clinical and regulatory acceptance of nanomedicine through various agencies. Additionally, the review summarizes key issues involving industrial implementation; from analytical limitations and barriers to the realization of the process on industrial scale, to stability issues and long-term safety evaluation; and emerging strategies including real-time monitoring, automation and advanced process control. By integrating QbD with DoE, industries can develop reproducible, efficient and scalable production processes for manufacturing nanoparticles.
- 7 September 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 98-107
Open AccessIntegrating Quality by Design and Design of Experiments for Scalable Nanoparticle Therapeutics: A Comprehensive Review
Nanoparticle-based drug delivery systems have tremendous advantages over the conventional dosage forms in terms of enhancing bioavailability, controlled release and tissue-specific targeting. However, despite great success at laboratory scale, the translation and commercialization of nanomedicines is still limited, mainly due to the inherent complexity of nanosystems, variability of the manufacturing processes and lack of globally unified regulatory frameworks. Integrating quality by design (QbD) with design of experiments (DoE) offers a scientific process for filling these gaps with more comprehensive formulation and understanding of processes. This review outlines QbD driven methodologies employed in the development of nanoparticles with a focus on the systematic determination of the quality target product profile (QTPP), critical quality attributes (CQAs), critical material attributes (CMAs), and critical process parameters (CPPs). The usefulness of DoEin screening and optimization methodology and multifactorial variables of formulation types is reviewed as a tool to derive robust design spaces and promote and provide predictive activity of nanoparticles such as particle size, polydispersity, drug loading, release kinetics, stability, etc. Updated knowledge about globally approved nanotechnology-based products is in the light of the rising clinical and regulatory acceptance of nanomedicine through various agencies. Additionally, the review summarizes key issues involving industrial implementation; from analytical limitations and barriers to the realization of the process on industrial scale, to stability issues and long-term safety evaluation; and emerging strategies including real-time monitoring, automation and advanced process control. By integrating QbD with DoE, industries can develop reproducible, efficient and scalable production processes for manufacturing nanoparticles.
- Open Access
- 6 January 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
IN SILICO INVESTIGATION OF CONVOLVULUS PROSTRATUS AS A POTENTIAL SOURCE OF Α-GLUCOSIDASE INHIBITORS FOR DIABETIC MANAGEMENT
Objective: Diabetes mellitus (DM) remains a major global health concern, and inhibition of intestinal α-glucosidase is a well-established therapeutic approach for managing postprandial hyperglycemia. Convolvulus prostrates (C. prostratus) contains several phytochemicals with reported antidiabetic relevance. This study aimed to computationally assess selected constituents from C. prostratus for their potential α-glucosidase interactions using an integrated in silico strategy. Methods: Molecular docking, molecular mechanics–generalized born surface area binding free energy calculations, 100 ns molecular dynamics (MD) simulations, and absorption, distribution, metabolism, excretion, and toxicity predictions were performed to evaluate the interaction profiles and drug-likeness of prioritized phytoconstituents against human maltase–glucoamylase (PDB ID: 3TOP). Results: Among the screened compounds, A18 (identified as quercetin, a well-known flavonoid previously reported in C. prostratus), showed comparatively favorable docking affinity (ΔG = −9.549 kcal/mol) and MM-GBSA binding energy (ΔG_bind = −31.44 kcal/mol) relative to the other constituents evaluated. MD simulations indicated that the quercetin–enzyme complex maintained stable binding, with consistent interactions involving key catalytic residues such as Asp1157, Asp1279, and Asp1526. ADMET profiling suggested good oral absorption and acceptable physicochemical characteristics, while noting that its predicted blood–brain barrier permeability may represent a potential liability for an intestinal enzyme inhibitor. Conclusion: This study provides computational support for quercetin’s contributory role as one of the phytochemicals in C. prostratus capable of interacting with α-glucosidase. While quercetin demonstrated favorable in silico interaction and pharmacokinetic features compared with the other evaluated constituents, these findings primarily reinforce its known bioactivity and highlight the need for further in vitro and in vivo validation to substantiate its therapeutic relevance.
- 6 January 2026
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
Open AccessIN SILICO INVESTIGATION OF CONVOLVULUS PROSTRATUS AS A POTENTIAL SOURCE OF Α-GLUCOSIDASE INHIBITORS FOR DIABETIC MANAGEMENT
Objective: Diabetes mellitus (DM) remains a major global health concern, and inhibition of intestinal α-glucosidase is a well-established therapeutic approach for managing postprandial hyperglycemia. Convolvulus prostrates (C. prostratus) contains several phytochemicals with reported antidiabetic relevance. This study aimed to computationally assess selected constituents from C. prostratus for their potential α-glucosidase interactions using an integrated in silico strategy. Methods: Molecular docking, molecular mechanics–generalized born surface area binding free energy calculations, 100 ns molecular dynamics (MD) simulations, and absorption, distribution, metabolism, excretion, and toxicity predictions were performed to evaluate the interaction profiles and drug-likeness of prioritized phytoconstituents against human maltase–glucoamylase (PDB ID: 3TOP). Results: Among the screened compounds, A18 (identified as quercetin, a well-known flavonoid previously reported in C. prostratus), showed comparatively favorable docking affinity (ΔG = −9.549 kcal/mol) and MM-GBSA binding energy (ΔG_bind = −31.44 kcal/mol) relative to the other constituents evaluated. MD simulations indicated that the quercetin–enzyme complex maintained stable binding, with consistent interactions involving key catalytic residues such as Asp1157, Asp1279, and Asp1526. ADMET profiling suggested good oral absorption and acceptable physicochemical characteristics, while noting that its predicted blood–brain barrier permeability may represent a potential liability for an intestinal enzyme inhibitor. Conclusion: This study provides computational support for quercetin’s contributory role as one of the phytochemicals in C. prostratus capable of interacting with α-glucosidase. While quercetin demonstrated favorable in silico interaction and pharmacokinetic features compared with the other evaluated constituents, these findings primarily reinforce its known bioactivity and highlight the need for further in vitro and in vivo validation to substantiate its therapeutic relevance.
- 9 September 2025
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 84 (2) , 409-434
Nutritional and Pharmacological Significance of Pomegranate ( Punica granatum L ): A Comprehensive Narrative Review
Pomegranate (Punica granatum L) is a rich source of bioactive compounds, including punicalagin, ellagic acid, anthocyanins, and urolithins, which contribute to its broad pharmacological potential. This review summarizes evidence from in vitro and in vivo experiments, as well as clinical studies, highlighting pomegranate’s therapeutic effects in inflammation, metabolic disorders, cancer, cardiovascular disease, neurodegeneration, microbial infections, and skin conditions. Mechanistic insights show modulation of pathways such as nuclear factor–kappa B (NF-κB), mitogen-activated protein kinase (MAPK), alpha serine/threonine-protein kinase (AKT1), and nuclear factor erythroid 2–related factor 2 (Nrf2). Notably, punicalagin exhibits antifungal activity via sterol 14-demethylase P450 (CYP51) inhibition, supported by molecular docking studies. While evidence supports the promising bioactivity of pomegranate compounds, their clinical application is hindered by low and variable bioavailability, inconsistent dosing and formulations, and limited data on adverse effects largely due to interindividual differences in gut microbiota metabolism of punicalagin into urolithins. Although pomegranate demonstrates an excellent safety profile with minimal reported adverse events, further long-term, well-designed clinical trials are essential to validate its efficacy, determine optimal dosing, and enable standardized therapeutic use. This review contributes to the discourse on the medicinal value of pomegranate, offering a comprehensive understanding of its role in addressing diverse health conditions and highlighting the importance of integrating medicinal plants such as pomegranate into modern nutrition and clinical practice.
- 9 September 2025
- Published by Oxford University Press (OUP) in Nutrition Reviews
- Vol. 84 (2) , 409-434
Nutritional and Pharmacological Significance of Pomegranate ( Punica granatum L ): A Comprehensive Narrative Review
Pomegranate (Punica granatum L) is a rich source of bioactive compounds, including punicalagin, ellagic acid, anthocyanins, and urolithins, which contribute to its broad pharmacological potential. This review summarizes evidence from in vitro and in vivo experiments, as well as clinical studies, highlighting pomegranate’s therapeutic effects in inflammation, metabolic disorders, cancer, cardiovascular disease, neurodegeneration, microbial infections, and skin conditions. Mechanistic insights show modulation of pathways such as nuclear factor–kappa B (NF-κB), mitogen-activated protein kinase (MAPK), alpha serine/threonine-protein kinase (AKT1), and nuclear factor erythroid 2–related factor 2 (Nrf2). Notably, punicalagin exhibits antifungal activity via sterol 14-demethylase P450 (CYP51) inhibition, supported by molecular docking studies. While evidence supports the promising bioactivity of pomegranate compounds, their clinical application is hindered by low and variable bioavailability, inconsistent dosing and formulations, and limited data on adverse effects largely due to interindividual differences in gut microbiota metabolism of punicalagin into urolithins. Although pomegranate demonstrates an excellent safety profile with minimal reported adverse events, further long-term, well-designed clinical trials are essential to validate its efficacy, determine optimal dosing, and enable standardized therapeutic use. This review contributes to the discourse on the medicinal value of pomegranate, offering a comprehensive understanding of its role in addressing diverse health conditions and highlighting the importance of integrating medicinal plants such as pomegranate into modern nutrition and clinical practice.
- 12 September 2024
- Published by Springer Nature
- p. 243-269
Polymer-Based Carriers for Targeting Lymphatic System
- 12 September 2024
- Published by Springer Nature
- p. 243-269
Polymer-Based Carriers for Targeting Lymphatic System
- Open Access
- 4 April 2023
- Published by Ayurveda Sahiti Prabha in International Journal of Ayurvedic Medicine
- Vol. 14 (1) , 244-252
Optimization and Evaluation of Anti-Inflammatory Herbal Emulgel loaded with Vitex Negundo for Enhanced Permeation
The use of conventional drugs for the treatment of pain and inflammation has largely resulted in various side effects. These challenges have triggered the search for alternative therapy such as herbal medication that may serve as a safe, effective, and alternate treatment approach to managing pain and inflammation. Vitex negundo, a potential lipophilic molecule, possesses limited solubility and permeability. Emulgels are either water-in-oil or oil-in-water type emulsions, mixed with a gelling agent to form a gel for the delivery of lipophilic active ingredients. Therefore the current study is undertaken for the effective delivery of vitex negundo locally in the form of oil-in-water emulgel for improving solubility and permeability. The emulgel was formulated from carbopol 934 with vitex negundo in mineral oil emulsion using tween 80 (surfactant), and triethanolamine (co-surfactant). The formulations were optimized using the design of experiment software. The optimized emulgel formulation containing Smix (tween 80 and triethanolamine) ratio of 61.90, mineral oil 50.58%, and carbopol 934 3% showed a pH of 6.5±0.3, a viscosity of 17793 – 939 cps, and spreadability of 7.07 g.cm/s. Data from in-vitro and ex-vivo diffusion studies demonstrated improved permeability properties. The stability of the optimized emulgel formulation was additionally examined at ambient temperature for 28 days. The emulgel remained stable for 28 days. Based on the overall results we can conclude that emulgel can be a promising and suitable formulation for the application of vitex negundo.
- 4 April 2023
- Published by Ayurveda Sahiti Prabha in International Journal of Ayurvedic Medicine
- Vol. 14 (1) , 244-252
Open AccessOptimization and Evaluation of Anti-Inflammatory Herbal Emulgel loaded with Vitex Negundo for Enhanced Permeation
The use of conventional drugs for the treatment of pain and inflammation has largely resulted in various side effects. These challenges have triggered the search for alternative therapy such as herbal medication that may serve as a safe, effective, and alternate treatment approach to managing pain and inflammation. Vitex negundo, a potential lipophilic molecule, possesses limited solubility and permeability. Emulgels are either water-in-oil or oil-in-water type emulsions, mixed with a gelling agent to form a gel for the delivery of lipophilic active ingredients. Therefore the current study is undertaken for the effective delivery of vitex negundo locally in the form of oil-in-water emulgel for improving solubility and permeability. The emulgel was formulated from carbopol 934 with vitex negundo in mineral oil emulsion using tween 80 (surfactant), and triethanolamine (co-surfactant). The formulations were optimized using the design of experiment software. The optimized emulgel formulation containing Smix (tween 80 and triethanolamine) ratio of 61.90, mineral oil 50.58%, and carbopol 934 3% showed a pH of 6.5±0.3, a viscosity of 17793 – 939 cps, and spreadability of 7.07 g.cm/s. Data from in-vitro and ex-vivo diffusion studies demonstrated improved permeability properties. The stability of the optimized emulgel formulation was additionally examined at ambient temperature for 28 days. The emulgel remained stable for 28 days. Based on the overall results we can conclude that emulgel can be a promising and suitable formulation for the application of vitex negundo.
- Open Access
- 25 February 2023
- Published by Wiley
Pharmacovigilance Systems and Strategies: Importance of Post-Marketing Surveillance for Ensuring Drug Safety and Patient Health in Europe, United States, and India
After a drug is granted a marketing license, its post-marketing surveillance is evaluated to ensure that it is continuously monitored for undesirable effects. This monitoring is achieved through an effective Pharmacovigilance system. In our review, we discuss the Pharmacovigilance systems of Europe, the United States, and India, along with several examples of effective Pharmacovigilance strategies, such as the Tracleer® Access Programme and Tracleer® Excellence programs for Bosentan, Merck’s Worldwide Adverse Experience System, the European and United States Varicella Zoster Virus Identification Programs for Varivax, the Siddha Initiative for Documentation of Drug Adverse Reaction, an android mobile app for AYUSH Pharmacovigilance, and the Global Pharmacovigilance Database by Sanofi Pasteur. This report demonstrates the importance of post-marketing surveillance in detecting rare adverse experiences that may go unnoticed during clinical trials. It also emphasizes the significance of highlighting the field of Pharmacovigilance to improve patient safety and offer them the best possible quality of life.
- 25 February 2023
- Published by Wiley
Open AccessPharmacovigilance Systems and Strategies: Importance of Post-Marketing Surveillance for Ensuring Drug Safety and Patient Health in Europe, United States, and India
After a drug is granted a marketing license, its post-marketing surveillance is evaluated to ensure that it is continuously monitored for undesirable effects. This monitoring is achieved through an effective Pharmacovigilance system. In our review, we discuss the Pharmacovigilance systems of Europe, the United States, and India, along with several examples of effective Pharmacovigilance strategies, such as the Tracleer® Access Programme and Tracleer® Excellence programs for Bosentan, Merck’s Worldwide Adverse Experience System, the European and United States Varicella Zoster Virus Identification Programs for Varivax, the Siddha Initiative for Documentation of Drug Adverse Reaction, an android mobile app for AYUSH Pharmacovigilance, and the Global Pharmacovigilance Database by Sanofi Pasteur. This report demonstrates the importance of post-marketing surveillance in detecting rare adverse experiences that may go unnoticed during clinical trials. It also emphasizes the significance of highlighting the field of Pharmacovigilance to improve patient safety and offer them the best possible quality of life.
- Open Access
- 8 February 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 574
Ultrasonically Fabricated Beta-Carotene Nanoemulsion: Optimization, Characterization and Evaluation of Combinatorial Effect with Quercetin on Streptozotocin-Induced Diabetic Rat Model
Diabetes mellitus (D.M.) is a metabolic disease that has affected over 500 million people globally. Bioactive compounds such as β-carotene and Quercetin have gained research interest for their potential antidiabetic properties, and bioactives have reported superior combinatorial effects in several ailments, including D.M. However, poor oral bioavailability has limited their potential application. Thus, the present study was focused on developing ultrasonically fabricated β-Carotene nanoemulsion (βC-NE) by employing capmul as the oil phase, Gelucire 44/14 as surfactant and Acconon MCM C8 as co-surfactant. The 3 factor- 3 level Box-Behnken design (BBD) was applied to optimise the βC-NE and study the impact of selected independent variables such as % Smix (5 to 9%), amplitude (20–30%) and sonication time (2.5–7.5 min) on responses including globule size (G.S.), poly dispersibility Index (PDI) and entrapment efficiency (E.E.). Further, the combinatorial effect of βC-NE with Quercetin Nanoemulsion (QU-NE) in the streptozotocin-induced diabetic rat model was evaluated. The results exhibited that 7% Smix at 25% amplitude for 5 min produced βC-NE with a droplet size of 153.1 ± 12.25 nm, 0.200 ± 0.04 PDI, and 73.25 ± 3.25% E.E. The βC-NE showed superior in-vivo bioavailability by 5.38 folds. The βC-NE, combined with QU-NE, exhibited potential therapeutic benefits in controlling body weight, blood sugar level, lipid levels, and tissue damage markers. Additionally, the pancreatic cells and hepatic cells were well protected. These results demonstrate the potential benefits of βC-NE and QU-NE in combination and recommend them as a substitute strategy for diabetes.
- 8 February 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 574
Open AccessUltrasonically Fabricated Beta-Carotene Nanoemulsion: Optimization, Characterization and Evaluation of Combinatorial Effect with Quercetin on Streptozotocin-Induced Diabetic Rat Model
Diabetes mellitus (D.M.) is a metabolic disease that has affected over 500 million people globally. Bioactive compounds such as β-carotene and Quercetin have gained research interest for their potential antidiabetic properties, and bioactives have reported superior combinatorial effects in several ailments, including D.M. However, poor oral bioavailability has limited their potential application. Thus, the present study was focused on developing ultrasonically fabricated β-Carotene nanoemulsion (βC-NE) by employing capmul as the oil phase, Gelucire 44/14 as surfactant and Acconon MCM C8 as co-surfactant. The 3 factor- 3 level Box-Behnken design (BBD) was applied to optimise the βC-NE and study the impact of selected independent variables such as % Smix (5 to 9%), amplitude (20–30%) and sonication time (2.5–7.5 min) on responses including globule size (G.S.), poly dispersibility Index (PDI) and entrapment efficiency (E.E.). Further, the combinatorial effect of βC-NE with Quercetin Nanoemulsion (QU-NE) in the streptozotocin-induced diabetic rat model was evaluated. The results exhibited that 7% Smix at 25% amplitude for 5 min produced βC-NE with a droplet size of 153.1 ± 12.25 nm, 0.200 ± 0.04 PDI, and 73.25 ± 3.25% E.E. The βC-NE showed superior in-vivo bioavailability by 5.38 folds. The βC-NE, combined with QU-NE, exhibited potential therapeutic benefits in controlling body weight, blood sugar level, lipid levels, and tissue damage markers. Additionally, the pancreatic cells and hepatic cells were well protected. These results demonstrate the potential benefits of βC-NE and QU-NE in combination and recommend them as a substitute strategy for diabetes.
- Open Access
- 29 August 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1812
Design, Formulation, and Evaluation of Aloe vera Gel-Based Capsaicin Transemulgel for Osteoarthritis
Topical treatments are a potential therapeutic option for the therapy of osteoarthritis, with significant data supporting the effectiveness and safety of topical formulation. Topical gel formulations may offer an alternative to oral formulations to relieve osteoarthritis (OA) pain while decreasing systemic exposure. Topical capsaicin transemulgel may represent an effective and safe alternative. The transemulgel was prepared from aqueous Aloe vera gel and Carbopol 934 with capsaicin in clove oil emulsion. The optimized transemulgel of capsaicin showed a pH of 6.1 ± 0.1 and viscosity of 15263–998 cps. Data from in vitro diffusion demonstrated improved permeability properties. The formulation caused no skin irritation when applied topically. The optimal transemulgel spreadability was found to be 20.23 g·cm/s. In vitro and ex vivo studies of the optimized formulation were performed. The skin irritant test was performed on rat skin with an optimized and marketed formulation. Both showed no irritation on the skin. The transemulgel of the capsaicin with Aloe vera gel was proven to be effective for osteoarthritis therapy.
- 29 August 2022
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (9) , 1812
Open AccessDesign, Formulation, and Evaluation of Aloe vera Gel-Based Capsaicin Transemulgel for Osteoarthritis
Topical treatments are a potential therapeutic option for the therapy of osteoarthritis, with significant data supporting the effectiveness and safety of topical formulation. Topical gel formulations may offer an alternative to oral formulations to relieve osteoarthritis (OA) pain while decreasing systemic exposure. Topical capsaicin transemulgel may represent an effective and safe alternative. The transemulgel was prepared from aqueous Aloe vera gel and Carbopol 934 with capsaicin in clove oil emulsion. The optimized transemulgel of capsaicin showed a pH of 6.1 ± 0.1 and viscosity of 15263–998 cps. Data from in vitro diffusion demonstrated improved permeability properties. The formulation caused no skin irritation when applied topically. The optimal transemulgel spreadability was found to be 20.23 g·cm/s. In vitro and ex vivo studies of the optimized formulation were performed. The skin irritant test was performed on rat skin with an optimized and marketed formulation. Both showed no irritation on the skin. The transemulgel of the capsaicin with Aloe vera gel was proven to be effective for osteoarthritis therapy.
- Open Access
- 3 October 2021
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 17 (1) , 20-34
Exosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus- SARS-CoV-2
- 3 October 2021
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 17 (1) , 20-34
Open AccessExosomes: Emerging implementation of nanotechnology for detecting and managing novel corona virus- SARS-CoV-2